Pfizer (PFE) Named Global Top Pick at Jefferies

Jefferies analyst Jeffrey Holford made Pfizer (NYSE: PFE) its Global 'Top Pick' in the sector while reiterating a Buy rating and price target of $47.

Holford expects fundamentals and self help through M&A and restructuring to drive outperformance.

AbbVie (NYSE: ABBV), which is in 2nd place, remains significantly undervalued in their view. The firm maintained a Buy rating and trimmed its price target to $85.

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $31.96 yesterday.

You May Also Be Interested In

• Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,300 at Jefferies
• Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,750 at Morgan Stanley
• FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer